<?xml version="1.0" encoding="UTF-8"?>
<p>The anti-HCMV effects of eltrombopag are unlikely to be caused by action on the thrombopoietin receptor, since eltrombopag was effective in cell types that do not express the thrombopoietin receptor, which is expressed in hematopoietic cells [
 <xref rid="B28-cells-09-00031" ref-type="bibr">28</xref>,
 <xref rid="B29-cells-09-00031" ref-type="bibr">29</xref>]. In agreement, eltrombopag also exerted antiviral effects in mouse fibroblasts infected with murine CMV, although the hematological effects of eltrombopag are known to be species-specific and to not affect mice [
 <xref rid="B28-cells-09-00031" ref-type="bibr">28</xref>,
 <xref rid="B29-cells-09-00031" ref-type="bibr">29</xref>].
</p>
